Cross Country Healthcare Stock Beta
| XXY Stock | EUR 17.10 0.10 0.58% |
Cross Country Healthcare fundamentals help investors to digest information that contributes to Cross Country's financial success or failures. It also enables traders to predict the movement of Cross Stock. The fundamental analysis module provides a way to measure Cross Country's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cross Country stock.
Cross |
Cross Country Healthcare Company Beta Analysis
Cross Country's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Cross Country Beta | 1.05 |
Most of Cross Country's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cross Country Healthcare is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, Cross Country Healthcare has a Beta of 1.0457. This is 23.67% lower than that of the Industrials sector and 45.82% lower than that of the Staffing & Outsourcing Services industry. The beta for all Germany stocks is notably lower than that of the firm.
Did you try this?
Run Global Markets Map Now
Global Markets MapGet a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |
| All Next | Launch Module |
Cross Country returns are very sensitive to returns on the market. As the market goes up or down, Cross Country is expected to follow.
Cross Fundamentals
| Return On Equity | 0.5 | |||
| Return On Asset | 0.21 | |||
| Profit Margin | 0.07 % | |||
| Operating Margin | 0.10 % | |||
| Current Valuation | 1.18 B | |||
| Shares Outstanding | 36.82 M | |||
| Shares Owned By Insiders | 5.37 % | |||
| Shares Owned By Institutions | 99.85 % | |||
| Price To Earning | 6.82 X | |||
| Price To Book | 2.66 X | |||
| Price To Sales | 0.35 X | |||
| Revenue | 2.81 B | |||
| Gross Profit | 627.69 M | |||
| EBITDA | 283.29 M | |||
| Net Income | 188.46 M | |||
| Cash And Equivalents | 24.83 M | |||
| Cash Per Share | 0.67 X | |||
| Total Debt | 148.74 M | |||
| Debt To Equity | 59.00 % | |||
| Current Ratio | 1.99 X | |||
| Book Value Per Share | 12.60 X | |||
| Cash Flow From Operations | 134.05 M | |||
| Earnings Per Share | 5.67 X | |||
| Price To Earnings To Growth | 0.96 X | |||
| Target Price | 20.71 | |||
| Number Of Employees | 2.7 K | |||
| Beta | 1.05 | |||
| Market Capitalization | 925.43 M | |||
| Total Asset | 947.84 M | |||
| Z Score | 5.6 | |||
| Net Asset | 947.84 M |
About Cross Country Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cross Country Healthcare's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cross Country using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cross Country Healthcare based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Cross Stock
When determining whether Cross Country Healthcare offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cross Country's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cross Country Healthcare Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cross Country Healthcare Stock:Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Cross Country Healthcare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..